In module 4, vascular endothelial growth factor-A (VEGF-A) and CRKL were highly functionally active and involved in both “focal adhesion” and “pathways in cancer” pathways annotated in module 4 (Table 4, Figure 4). The gene discussed is VEGFA; the disease is cancer.